Additional file 2 of Zinc transporter SLC39A13/ZIP13 facilitates the metastasis of human ovarian cancer cells via activating Src/FAK signaling pathway

Additional file 2: Table S1. Clinical properties of the ovarian cancer patients used in the analysis. Table S2. Summary of the sequences of ZIP13 sgRNAs and primers for CRISPR. Table S3. Primers used in quantitative real-time RT-PCR. Table S4. The association of ZIP transporters with overall survival (OS) and progression-free survival (PFS) in patients with serous ovarian cancer. Table S5. Correlation of ZIP13 gene expression with survival in different clinical stages in ovarian cancer patients. Table S6. Correlation of ZIP13 gene expression with survival in different pathological grades in ovarian cancer patients. Table S7. KEGG pathway enrichment analysis of the ZIP13-regulated genes. Table S8. GO analysis of the biological processes associated with ZIP13-regulated genes. Table S9. GO analysis of the molecular functions associated with ZIP13-regulated genes. Table S10. KEGG pathway enrichment analysis of the ZIP13-regulated genes in ovarian cancer patients from TCGA.

附加文件2：表S1 本分析所用卵巢癌患者的临床特征。表S2 CRISPR实验中ZIP13单导RNA（single guide RNA, sgRNA）及引物的序列汇总。表S3 定量实时逆转录聚合酶链反应（quantitative real-time reverse transcription polymerase chain reaction, qRT-PCR）所用引物。表S4 浆液性卵巢癌患者中ZIP转运蛋白与总生存期（overall survival, OS）及无进展生存期（progression-free survival, PFS）的相关性分析。表S5 卵巢癌患者不同临床分期下ZIP13基因表达与生存期的相关性。表S6 卵巢癌患者不同病理分级下ZIP13基因表达与生存期的相关性。表S7 ZIP13调控基因的京都基因与基因组百科全书（Kyoto Encyclopedia of Genes and Genomes, KEGG）通路富集分析。表S8 ZIP13调控基因相关生物学过程的基因本体（Gene Ontology, GO）分析。表S9 ZIP13调控基因相关分子功能的基因本体分析。表S10 癌症基因组图谱（The Cancer Genome Atlas, TCGA）卵巢癌患者队列中ZIP13调控基因的KEGG通路富集分析。